Tags: Cancer | Heart Disease | aspirin | cancer | cervical | study

Daily Aspirin Cuts Cervical Cancer Risk in Half: Study

By    |   Friday, 01 May 2015 12:59 PM

Women who use daily aspirin therapy for heart disease prevention may cut their cervical cancer by nearly 50 percent, a new study shows.

Aspirin use was associated with a 47 percent reduced risk of cervical cancer among frequent users - those who used aspirin seven or more times a week, regardless of duration.

Acetaminophen (Tylenol) was not associated with decreased risk of cervical cancer.

“Aspirin use remains an attractive cancer-prevention option, due to the fact that most people will be more likely to take a pill rather than make major lifestyle modifications such as quitting smoking, eating a healthy diet and engaging in physical activity,” said Dr. Kristen Moysich, the study’s lead author. Women should consult their doctors before starting an aspirin regimen, she added.

About 12,900 new cases of cervical cancer are diagnosed each year, resulting in approximately 4,100 deaths. Study participants were drawn from 26,831 patients who received treatment at Roswell Park Cancer Institute in Buffalo, N.Y.

© 2020 NewsmaxHealth. All rights reserved.

   
1Like our page
2Share
Health-News
Women who use daily aspirin therapy for heart disease prevention may cut their cervical cancer by nearly 50 percent, a new study shows. Aspirin use was associated with a 47 percent reduced risk of cervical cancer among frequent users - those who used aspirin seven or more...
aspirin, cancer, cervical, study
159
2015-59-01
Friday, 01 May 2015 12:59 PM
Newsmax Media, Inc.
 

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved